Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins

被引：23
|
作者：
Abraham, JD
Himoudi, N
Kien, F
Berland, JL
Codran, A
Bartosch, B
Baumert, T
Paranhos-Baccala, G
Schuster, C
Inchauspé, G
Kieny, MP
机构：
[1] INSERM, U544, Inst Virol, F-67000 Strasbourg, France
[2] Ecole Normale Super Lyon, CNRS, UMR 2142, BioMerieux, F-69364 Lyon 07, France
[3] CERVI, CNRS, UMR 2142, BioMerieux, F-69364 Lyon 07, France
[4] Ecole Normale Super Lyon, INSERM, U412, IFR 128, F-69364 Lyon 07, France
[5] Univ Freiburg, Dept Med 2, Freiburg, Germany
来源：
VACCINE | 2004年 / 22卷 / 29-30期
关键词：
HCV; MVA; immunization; humoral and cellular responses;
D O I：
10.1016/j.vaccine.2004.04.005
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We have evaluated in C57[1316 and HLA-A2.1 transgenic mice the immunogenicity of three MVA vectors expressing either native HCV El E2 polyprotein. truncated and secreted El (E'1 (311)) and E2 (E'2(661)) proteins, or a chimeric El E2 heterodimer presented at the plasma membrane. Immunization induced mainly a Th1 response in HLA-A2.1 transgenic mice while a Th2-type response was detected in C57/B16 mice. Comparison of the three vectors shows an increase in the humoral response when antigens are secreted or membrane bound, and slightly in the cellular response when antigens are exposed on the cell surface. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3917 / 3928
页数：12
相关论文
共 33 条
  • [1] Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2
    Nayak, Aparajita
    Pattabiraman, Nagarajan
    Fadra, Numrah
    Goldman, Radoslav
    Pond, Sergei L. Kosakovsky
    Mazumder, Raja
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (08) : 1682 - 1694
  • [2] Immunological Characterization of a Modified Vaccinia Virus Ankara Vector Expressing the Human Papillomavirus 16 E1 Protein
    Remy-Ziller, Christelle
    Germain, Claire
    Spindler, Anita
    Hoffmann, Chantal
    Silvestre, Nathalie
    Rooke, Ronald
    Bonnefoy, Jean-Yves
    Preville, Xavier
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (02) : 147 - 155
  • [3] Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
    Marin, Maria Q.
    Sliepen, Kwinten
    Garcia-Arriaza, Juan
    Koekkoek, Sylvie M.
    Perez, Patricia
    Sorzano, Carlos Oscar S.
    Gomez, Carmen E.
    Sanders, Rogier W.
    Esteban, Mariano
    VACCINES, 2020, 8 (03) : 1 - 25
  • [4] Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge
    van den Doel, Petra
    Volz, Asisa
    Roose, Jouke M.
    Sewbalaksing, Varsha D.
    Pijlman, Gorben P.
    van Middelkoop, Ingeborg
    Duiverman, Vincent
    de Wetering, Eva van
    Sutter, Gerd
    Osterhaus, Albert D. M. E.
    Martina, Byron E. E.
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (09):
  • [5] Transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation
    Patel, J
    Patel, AH
    McLauchlan, J
    VIROLOGY, 2001, 279 (01) : 58 - 68
  • [6] Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens
    Prentoe, Jannick
    Janitzek, Christoph M.
    Velazquez-Moctezuma, Rodrigo
    Goksoyr, Louise
    Olsen, Rebecca W.
    Fanalista, Margherita
    Augestad, Elias H.
    Thrane, Susan
    Pihl, Anne F.
    Gottwein, Judith M.
    Sander, Adam F.
    Bukh, Jens
    PLOS ONE, 2021, 16 (07):
  • [7] Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
    Meseda, Clement A.
    Atukorale, Vajini
    Soto, Jackeline
    Eichelberger, Maryna C.
    Gao, Jin
    Wang, Wei
    Weiss, Carol D.
    Weir, Jerry P.
    SCIENTIFIC REPORTS, 2018, 8
  • [8] Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties
    Beaumont, Elodie
    Roch, Emmanuelle
    Chopin, Lucie
    Roingeard, Philippe
    PLOS ONE, 2016, 11 (03):
  • [9] Expression of recombinant Hepatitis C virus (HCV) ore, E1 and E2 proteins by the baculovirus expression vector system
    Yazdani-Neyshabouri, Shaghayegh
    Aghasadeghi, Mohammad Reza
    Jahanian-Najafabadi, Ali
    Bouzari, Saeid
    Arashkia, Arash
    Sadat, Seyed Mehdi
    Siadat, Seyed Davar
    Sadigh, Zohre-Azita
    Hekmat, Sohiela
    Pouriayevali, Mohammad Hassan
    Kashanizadeh, Nafiseh
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2012, 6 (19): : 4152 - 4157
  • [10] Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
    Law, John L. M.
    Logan, Michael
    Wong, Jason
    Kundu, Juthika
    Hockman, Darren
    Landi, Amir
    Chen, Chao
    Crawford, Kevin
    Wininger, Mark
    Johnson, Janelle
    Prince, Catalina Mesa
    Dudek, Elzbieta
    Mehta, Ninad
    Tyrrell, D. Lorne
    Houghton, Michael
    JOURNAL OF VIROLOGY, 2018, 92 (11)
1234